NO985200D0 - Antimikrobiell behandling for herpes simplex virus, og andre infeksi°se sykdommer - Google Patents
Antimikrobiell behandling for herpes simplex virus, og andre infeksi°se sykdommerInfo
- Publication number
- NO985200D0 NO985200D0 NO985200A NO985200A NO985200D0 NO 985200 D0 NO985200 D0 NO 985200D0 NO 985200 A NO985200 A NO 985200A NO 985200 A NO985200 A NO 985200A NO 985200 D0 NO985200 D0 NO 985200D0
- Authority
- NO
- Norway
- Prior art keywords
- acid
- chloride
- composition
- herpes simplex
- echinacen
- Prior art date
Links
- 208000035473 Communicable disease Diseases 0.000 title abstract 2
- 230000000845 anti-microbial effect Effects 0.000 title abstract 2
- 241000700584 Simplexvirus Species 0.000 title 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 abstract 4
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 abstract 3
- YDDUMTOHNYZQPO-RVXRWRFUSA-N Cynarine Chemical compound O([C@@H]1C[C@@](C[C@H]([C@@H]1O)O)(OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDUMTOHNYZQPO-RVXRWRFUSA-N 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- YDDUMTOHNYZQPO-UHFFFAOYSA-N 1,3-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-4,5-dihydroxycyclohexanecarboxylic acid Natural products OC1C(O)CC(C(O)=O)(OC(=O)C=CC=2C=C(O)C(O)=CC=2)CC1OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDUMTOHNYZQPO-UHFFFAOYSA-N 0.000 abstract 2
- 244000133098 Echinacea angustifolia Species 0.000 abstract 2
- 240000004530 Echinacea purpurea Species 0.000 abstract 2
- LADVYSUMGRTFSZ-UHFFFAOYSA-N Isotussilagine Natural products C1CCN2CC(O)(C)C(C(=O)OC)C21 LADVYSUMGRTFSZ-UHFFFAOYSA-N 0.000 abstract 2
- 241001072983 Mentha Species 0.000 abstract 2
- 235000014435 Mentha Nutrition 0.000 abstract 2
- LADVYSUMGRTFSZ-QXFUBDJGSA-N Tussilagine Chemical compound C1CCN2C[C@](O)(C)[C@@H](C(=O)OC)[C@@H]21 LADVYSUMGRTFSZ-QXFUBDJGSA-N 0.000 abstract 2
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- -1 alkyl dimethylbenzylammonium chloride Chemical compound 0.000 abstract 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Chemical class C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 abstract 2
- 235000019270 ammonium chloride Nutrition 0.000 abstract 2
- 235000010208 anthocyanin Nutrition 0.000 abstract 2
- 239000004410 anthocyanin Substances 0.000 abstract 2
- 229930002877 anthocyanin Natural products 0.000 abstract 2
- 150000004636 anthocyanins Chemical class 0.000 abstract 2
- 239000012141 concentrate Substances 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 235000017807 phytochemicals Nutrition 0.000 abstract 2
- 229930000223 plant secondary metabolite Natural products 0.000 abstract 2
- 229920001197 polyacetylene Chemical class 0.000 abstract 2
- 239000004094 surface-active agent Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 abstract 2
- AURKDPLYMRHYAY-UHFFFAOYSA-N (+)-beta-caryophyllene-8,9-epoxy Natural products CC1=CCCC2(CO2)C3CC(C)(C)C3CC1 AURKDPLYMRHYAY-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 abstract 1
- GAIBLDCXCZKKJE-QRYCCKSOSA-N (-)-Germacrene D Natural products C(C)(C)[C@H]1/C=C/C(=C)CC/C=C(/C)\CC1 GAIBLDCXCZKKJE-QRYCCKSOSA-N 0.000 abstract 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- SHWRGPMBBKBLKB-FNORWQNLSA-N (3e)-pentadeca-1,3-diene Chemical class CCCCCCCCCCC\C=C\C=C SHWRGPMBBKBLKB-FNORWQNLSA-N 0.000 abstract 1
- APPMNDGEMXRQPR-FMIVXFBMSA-N (4e)-10-hydroxy-4,10-dimethyldodeca-4,11-dien-2-one Chemical compound CC(=O)C\C(C)=C\CCCCC(C)(O)C=C APPMNDGEMXRQPR-FMIVXFBMSA-N 0.000 abstract 1
- YDDUMTOHNYZQPO-WXAIXHMISA-N 1,3-Bis-(3,4-dihydroxy-cinnamoyl)-chinasaeure Natural products O[C@H]1C[C@](C[C@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@H]1O)(OC(=O)C=Cc3ccc(O)c(O)c3)C(=O)O YDDUMTOHNYZQPO-WXAIXHMISA-N 0.000 abstract 1
- YDDUMTOHNYZQPO-BBLPPJRLSA-N 1,3-di-O-caffeoylquinic acid Natural products O[C@@H]1C[C@@](C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)(OC(=O)C=Cc1ccc(O)c(O)c1)C(O)=O YDDUMTOHNYZQPO-BBLPPJRLSA-N 0.000 abstract 1
- OZIZFBLYKGBJPO-GCBRTHAASA-N 1,5-di-O-caffeoylquinic acid Natural products O[C@@H]1C[C@](C[C@@H](OC(=O)C=Cc2ccccc2)[C@H]1O)(OC(=O)C=Cc3ccccc3)C(=O)O OZIZFBLYKGBJPO-GCBRTHAASA-N 0.000 abstract 1
- PUAQLLVFLMYYJJ-UHFFFAOYSA-N 2-aminopropiophenone Chemical compound CC(N)C(=O)C1=CC=CC=C1 PUAQLLVFLMYYJJ-UHFFFAOYSA-N 0.000 abstract 1
- NCKMMSIFQUPKCK-UHFFFAOYSA-N 2-benzyl-4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1CC1=CC=CC=C1 NCKMMSIFQUPKCK-UHFFFAOYSA-N 0.000 abstract 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 abstract 1
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 abstract 1
- 241000234282 Allium Species 0.000 abstract 1
- 229920000189 Arabinogalactan Polymers 0.000 abstract 1
- 239000001904 Arabinogalactan Substances 0.000 abstract 1
- SWGKAHCIOQPKFW-JTNORFRNSA-N Caftaric acid Chemical compound OC(=O)[C@H](O)[C@H](C(O)=O)OC(=O)\C=C\C1=CC=C(O)C(O)=C1 SWGKAHCIOQPKFW-JTNORFRNSA-N 0.000 abstract 1
- 235000003880 Calendula Nutrition 0.000 abstract 1
- 240000001432 Calendula officinalis Species 0.000 abstract 1
- 235000002566 Capsicum Nutrition 0.000 abstract 1
- 240000008574 Capsicum frutescens Species 0.000 abstract 1
- 240000000467 Carum carvi Species 0.000 abstract 1
- 235000005747 Carum carvi Nutrition 0.000 abstract 1
- YDDGKXBLOXEEMN-IABMMNSOSA-L Chicoric acid Natural products C1=C(O)C(O)=CC=C1\C=C\C(=O)O[C@@H](C([O-])=O)[C@H](C([O-])=O)OC(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-L 0.000 abstract 1
- 241000159174 Commiphora Species 0.000 abstract 1
- 241000208308 Coriandrum Species 0.000 abstract 1
- SITQVDJAXQSXSA-CEZRHVESSA-N Cynarin Natural products O[C@@H]1C[C@@](C[C@H](O)[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)(OC(=O)C=Cc3cccc(O)c3O)C(=O)O SITQVDJAXQSXSA-CEZRHVESSA-N 0.000 abstract 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 abstract 1
- YDDGKXBLOXEEMN-UHFFFAOYSA-N Di-E-caffeoyl-meso-tartaric acid Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC(C(O)=O)C(C(=O)O)OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-UHFFFAOYSA-N 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 244000004281 Eucalyptus maculata Species 0.000 abstract 1
- 241000266331 Eugenia Species 0.000 abstract 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 abstract 1
- 241001071795 Gentiana Species 0.000 abstract 1
- GAIBLDCXCZKKJE-YZJXYJLZSA-N Germacren D Chemical compound CC(C)C/1CC\C(C)=C\CCC(=C)\C=C\1 GAIBLDCXCZKKJE-YZJXYJLZSA-N 0.000 abstract 1
- 208000009889 Herpes Simplex Diseases 0.000 abstract 1
- 241000132446 Inula Species 0.000 abstract 1
- 229920001202 Inulin Polymers 0.000 abstract 1
- 241000721662 Juniperus Species 0.000 abstract 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 abstract 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 abstract 1
- 241000522650 Myroxylon Species 0.000 abstract 1
- 241001529744 Origanum Species 0.000 abstract 1
- 235000011203 Origanum Nutrition 0.000 abstract 1
- AVFIYMSJDDGDBQ-UHFFFAOYSA-N Parthenium Chemical compound C1C=C(CCC(C)=O)C(C)CC2OC(=O)C(=C)C21 AVFIYMSJDDGDBQ-UHFFFAOYSA-N 0.000 abstract 1
- 241001495454 Parthenium Species 0.000 abstract 1
- 240000004760 Pimpinella anisum Species 0.000 abstract 1
- 235000012550 Pimpinella anisum Nutrition 0.000 abstract 1
- 241001127637 Plantago Species 0.000 abstract 1
- 241001529742 Rosmarinus Species 0.000 abstract 1
- 235000003976 Ruta Nutrition 0.000 abstract 1
- 240000005746 Ruta graveolens Species 0.000 abstract 1
- PLVVKSPVSVMLET-UHFFFAOYSA-N [Cl-].C(C(C)C)C([NH+](C)CCOCCOC1=CC=CC=C1)CC(C)C Chemical compound [Cl-].C(C(C)C)C([NH+](C)CCOCCOC1=CC=CC=C1)CC(C)C PLVVKSPVSVMLET-UHFFFAOYSA-N 0.000 abstract 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 abstract 1
- 229930013930 alkaloid Natural products 0.000 abstract 1
- 150000003797 alkaloid derivatives Chemical class 0.000 abstract 1
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 abstract 1
- SBXYHCVXUCYYJT-UEOYEZOQSA-N alpha-Sanshool Chemical compound C\C=C\C=C\C=C/CC\C=C\C(=O)NCC(C)C SBXYHCVXUCYYJT-UEOYEZOQSA-N 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 150000003863 ammonium salts Chemical class 0.000 abstract 1
- 235000019312 arabinogalactan Nutrition 0.000 abstract 1
- 229960001716 benzalkonium Drugs 0.000 abstract 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 abstract 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 229940115397 bornyl acetate Drugs 0.000 abstract 1
- SWGKAHCIOQPKFW-GHMZBOCLSA-N caffeoyltartaric acid Natural products OC(=O)[C@H](O)[C@H](C(O)=O)OC(=O)C=CC1=CC=C(O)C(O)=C1 SWGKAHCIOQPKFW-GHMZBOCLSA-N 0.000 abstract 1
- 239000001390 capsicum minimum Substances 0.000 abstract 1
- 229940117948 caryophyllene Drugs 0.000 abstract 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 abstract 1
- YDDGKXBLOXEEMN-IABMMNSOSA-N chicoric acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-N 0.000 abstract 1
- 229930016920 cichoric acid Natural products 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229950009125 cynarine Drugs 0.000 abstract 1
- YDDUMTOHNYZQPO-BKUKFAEQSA-N cynarine Natural products O[C@H]1C[C@@](C[C@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)(OC(=O)C=Cc3ccc(O)c(O)c3)C(=O)O YDDUMTOHNYZQPO-BKUKFAEQSA-N 0.000 abstract 1
- YDDGKXBLOXEEMN-PMACEKPBSA-N dicaffeoyl-D-tartaric acid Natural products O([C@H](C(=O)O)[C@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-PMACEKPBSA-N 0.000 abstract 1
- YDDGKXBLOXEEMN-WOJBJXKFSA-N dicaffeoyl-L-tartaric acid Natural products O([C@@H](C(=O)O)[C@@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-WOJBJXKFSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 235000014134 echinacea Nutrition 0.000 abstract 1
- FSBUXLDOLNLABB-ISAKITKMSA-N echinacoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC(=O)\C=C\C=2C=C(O)C(O)=CC=2)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O[C@@H](OCCC=2C=C(O)C(O)=CC=2)[C@@H]1O FSBUXLDOLNLABB-ISAKITKMSA-N 0.000 abstract 1
- NJYVDFDTLLZVMG-UHFFFAOYSA-N echinacoside Natural products CC1OC(OC2C(O)C(OCCc3ccc(O)c(O)c3)OC(COC4OC(CO)C(O)C(O)C4O)C2OC(=O)C=Cc5cc(O)cc(O)c5)C(O)C(O)C1O NJYVDFDTLLZVMG-UHFFFAOYSA-N 0.000 abstract 1
- OJIGFVZZEVQUNV-UHFFFAOYSA-N germacrene D Natural products CC(C)C1CCC=C(/C)CCC(=C)C=C1 OJIGFVZZEVQUNV-UHFFFAOYSA-N 0.000 abstract 1
- 229940097043 glucuronic acid Drugs 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 1
- 229940029339 inulin Drugs 0.000 abstract 1
- WFKAJVHLWXSISD-UHFFFAOYSA-N isobutyramide Chemical compound CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 abstract 1
- GAIBLDCXCZKKJE-UHFFFAOYSA-N isogermacrene D Natural products CC(C)C1CCC(C)=CCCC(=C)C=C1 GAIBLDCXCZKKJE-UHFFFAOYSA-N 0.000 abstract 1
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 abstract 1
- LADVYSUMGRTFSZ-XKSSXDPKSA-N methyl (1s,2r,8s)-2-hydroxy-2-methyl-1,3,5,6,7,8-hexahydropyrrolizine-1-carboxylate Chemical compound C1CCN2C[C@@](O)(C)[C@@H](C(=O)OC)[C@@H]21 LADVYSUMGRTFSZ-XKSSXDPKSA-N 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- SWUARLUWKZWEBQ-VQHVLOKHSA-N phenethyl caffeate Chemical compound C1=C(O)C(O)=CC=C1\C=C\C(=O)OCCC1=CC=CC=C1 SWUARLUWKZWEBQ-VQHVLOKHSA-N 0.000 abstract 1
- 239000001909 pimpinella anisum Substances 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 235000005806 ruta Nutrition 0.000 abstract 1
- 235000002020 sage Nutrition 0.000 abstract 1
- 239000008223 sterile water Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 229920001864 tannin Polymers 0.000 abstract 1
- 239000001648 tannin Substances 0.000 abstract 1
- 235000018553 tannin Nutrition 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- SWGKAHCIOQPKFW-UHFFFAOYSA-N trans-caffeoyl-tartaric acid Natural products OC(=O)C(O)C(C(O)=O)OC(=O)C=CC1=CC=C(O)C(O)=C1 SWGKAHCIOQPKFW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/646,988 US6355684B1 (en) | 1990-10-11 | 1996-05-08 | Antimicrobial treatment for herpes simplex virus and other infectious diseases |
| PCT/US1997/002468 WO1998011778A1 (en) | 1996-05-08 | 1997-03-12 | Antimicrobial treatment for herpes simplex virus and other infectious diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO985200D0 true NO985200D0 (no) | 1998-11-06 |
| NO985200L NO985200L (no) | 1999-01-08 |
| NO326139B1 NO326139B1 (no) | 2008-10-06 |
Family
ID=24595254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19985200A NO326139B1 (no) | 1996-05-08 | 1998-11-06 | Preparat omfattende et plantekjemikaliekonsentrat av Echinacea purpurea og benzalkoniumklorid. |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US6355684B1 (no) |
| EP (1) | EP0918458B1 (no) |
| JP (1) | JP2001505546A (no) |
| KR (1) | KR100347651B1 (no) |
| CN (1) | CN1113599C (no) |
| AP (1) | AP1356A (no) |
| AT (1) | ATE349159T1 (no) |
| AU (1) | AU716247B2 (no) |
| BG (1) | BG64522B1 (no) |
| BR (1) | BR9711086A (no) |
| CA (1) | CA2253736C (no) |
| CZ (1) | CZ295869B6 (no) |
| DE (1) | DE69737144T2 (no) |
| DK (1) | DK0918458T3 (no) |
| EA (1) | EA001339B1 (no) |
| EE (1) | EE04605B1 (no) |
| ES (1) | ES2278393T3 (no) |
| GE (1) | GEP20002132B (no) |
| HU (1) | HU229230B1 (no) |
| IL (2) | IL165980A (no) |
| IS (1) | IS4888A (no) |
| NO (1) | NO326139B1 (no) |
| NZ (1) | NZ332650A (no) |
| OA (1) | OA10917A (no) |
| PL (1) | PL188470B1 (no) |
| RS (1) | RS49721B (no) |
| SK (1) | SK285361B6 (no) |
| TR (1) | TR199802251T2 (no) |
| UA (1) | UA65537C2 (no) |
| WO (1) | WO1998011778A1 (no) |
Families Citing this family (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6355684B1 (en) * | 1990-10-11 | 2002-03-12 | Meryl J. Squires | Antimicrobial treatment for herpes simplex virus and other infectious diseases |
| US6350784B1 (en) * | 1996-02-12 | 2002-02-26 | Meryl J. Squires | Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
| US9662360B2 (en) * | 2008-10-09 | 2017-05-30 | Meritus Corporation | Treatment of herpes, pseudomonas, staph, and hepatitis |
| CN1087608C (zh) * | 1996-08-29 | 2002-07-17 | 中国人民解放军军事医学科学院放射医学研究所 | 二咖啡酰奎宁酸在治疗乙型肝炎及与逆转录病毒有关疾病中的用途及新咖啡酰奎宁酸衍生物 |
| AU9578898A (en) | 1997-09-24 | 1999-04-12 | Geoffrey N Richards | Composition and method for reducing pathogenic bacteria in food products |
| US6248343B1 (en) * | 1998-01-20 | 2001-06-19 | Ethicon, Inc. | Therapeutic antimicrobial compositions |
| DE19814905A1 (de) * | 1998-04-02 | 1999-10-07 | Michael O Ruepp Aar Pharma | Verwendung von Bärentraubenblätter (Arctostaphylos uva ursi)-, Birkenblätter (Betula)-, Schachtelhalmkraut (Equisetum)- und Brennessel (Urtica)-Extrakten |
| DE19814725A1 (de) * | 1998-04-02 | 1999-10-07 | Michael O Ruepp | Verwendung von Echinacea-pallida und Echinacea angustifolia-Extrakten; Löwenzahn-/Taraxacum)-Extrakten; Spitzwegerich-(Plantago)-Extrakten |
| WO1999055736A2 (en) * | 1998-04-27 | 1999-11-04 | Larex, Inc. | Derivatives of arabinogalactan and compositions including the same |
| US6162393A (en) * | 1998-08-06 | 2000-12-19 | Ndt, Inc. | Contact lens and ophthalmic solutions |
| US6759434B2 (en) | 1999-09-22 | 2004-07-06 | B. Ron Johnson | Anti-infective compositions, methods and systems for treating disordered tissue |
| US8173709B2 (en) * | 1999-09-22 | 2012-05-08 | Quadex Pharmaceuticals, Llc | Anti-infective methods for treating pathogen-induced disordered tissues |
| US6211243B1 (en) | 1999-09-22 | 2001-04-03 | B. Ron Johnson | Methods for treating cold sores with anti-infective compositions |
| PT1220680E (pt) | 1999-09-30 | 2008-06-25 | Factors R & D Technologies Ltd | Suplemento de echinacea e método de fabrico |
| US6306443B1 (en) | 2000-06-20 | 2001-10-23 | Amway Corporation | Method of increasing concentrations of caffeic acid derivatives and alkylamides and compositions containing the same |
| US6589513B2 (en) | 2000-09-20 | 2003-07-08 | Lesko-Care, L.L.C. | Oral hygiene formulation and method of use |
| US6632459B2 (en) * | 2000-12-11 | 2003-10-14 | Nutricia N.V. | Chlorogenic acid and an analog thereof for immune system stimulation |
| JP4280888B2 (ja) * | 2001-03-23 | 2009-06-17 | 独立行政法人産業技術総合研究所 | 生分解性多価カルボン酸エステル・カルボン酸の製造方法 |
| US6635679B2 (en) * | 2001-05-14 | 2003-10-21 | Akzo Nobel N.V. | Methods and compositions for inactivating viruses |
| IL143318A0 (en) | 2001-05-23 | 2002-04-21 | Herbal Synthesis Corp | Herbal compositions for the treatment of mucosal lesions |
| US6767546B1 (en) * | 2001-08-17 | 2004-07-27 | The United States Of America As Represented By The Secretary Of Agriculture | Use of echinacea as a feed additive to enhance protection against coccidiosis |
| ITMI20021691A1 (it) * | 2002-07-30 | 2004-01-30 | Indena Spa | Estratti di echinacea angustifolia |
| US7585523B2 (en) * | 2002-08-27 | 2009-09-08 | Targeted Medical Pharma | Composition and method to augment and sustain neurotransmitter production |
| DE10341579A1 (de) * | 2003-09-09 | 2005-04-07 | Bionorica Ag | Verwendung von Extrakten aus Gentiana lutea als antimikrobiell wirkendes Mittel |
| GB0326520D0 (en) * | 2003-11-13 | 2003-12-17 | Compton Developments Ltd | Molluscicidal and anti-barnacle compounds |
| DE102004005788A1 (de) * | 2004-02-06 | 2005-09-01 | Riemser Arzneimittel Ag | Zubereitungen enthaltend Echinacea-Auszüge und Thiocyanat |
| AU2005259854C1 (en) * | 2004-07-07 | 2011-06-02 | Integria Healthcare (Australia) PTY LTD | An Echinacea formulation |
| GB2432788C (en) * | 2004-07-07 | 2018-06-27 | Integria Healthcare Australia Pty Ltd | An echinacea formulation |
| FR2877576B1 (fr) * | 2004-11-08 | 2007-03-09 | Ahmed Kadri | Composition pharmaceutique utilisee pour stimuler la proliferation et l'activation des mastocytes |
| US7619008B2 (en) * | 2004-11-12 | 2009-11-17 | Kimberly-Clark Worldwide, Inc. | Xylitol for treatment of vaginal infections |
| EP1671535A1 (en) * | 2004-12-16 | 2006-06-21 | Stiftung Caesar Center of Advanced European Studies and Research | Methods for altering levels of phenolic compounds in plant cells |
| US20060217443A1 (en) * | 2005-03-28 | 2006-09-28 | Kimberly-Clark Worldwide, Inc. | Method for preventing and/or treating vaginal and vulval infections |
| AU2006251655B2 (en) * | 2005-05-20 | 2012-10-11 | Jack Arbiser | Proteasome inhibitors and uses thereof |
| US7786176B2 (en) * | 2005-07-29 | 2010-08-31 | Kimberly-Clark Worldwide, Inc. | Vaginal treatment composition containing xylitol |
| CA2660894C (en) | 2006-07-20 | 2018-12-04 | Izun Pharmaceuticals Corporation | Film-delivering rinse |
| KR100791282B1 (ko) | 2007-02-27 | 2008-01-04 | 재단법인 제주하이테크산업진흥원 | 미백활성을 나타내는 노루참나물 추출물 |
| US20080241290A1 (en) * | 2007-03-30 | 2008-10-02 | Wayne Jeffrey Perry | Sinus relief composition and method of producing the same |
| US8637094B2 (en) * | 2007-07-18 | 2014-01-28 | Iraj E. Kiani | Composition and method for treating viral conditions |
| US7850998B2 (en) * | 2007-07-18 | 2010-12-14 | Kiani Iraj E | Method of treating viral conditions |
| US7700137B1 (en) | 2007-07-18 | 2010-04-20 | Kiani Iraj E | Anti-viral compositions and method |
| US20090069446A1 (en) * | 2007-09-06 | 2009-03-12 | Wayne Jeffrey Perry | Dendritic salt therapeutic agent delivery system |
| CA2639512A1 (en) * | 2007-09-10 | 2009-03-10 | Sicap Industries, Llc | Nasal rinse additive |
| ITMI20080395A1 (it) * | 2008-03-10 | 2009-09-11 | Indena Spa | Formulazioni per il trattamento delle verruche e delle placche psoriatiche |
| CA2722211C (en) * | 2008-04-24 | 2017-02-14 | Indena S.P.A. | Compositions for the treatment of vaginal infections with chronic inflammation |
| EA201170239A1 (ru) * | 2008-07-22 | 2011-08-30 | Айзун Фармасьютикалз, Инк. | Противовоспалительная композиция для местного применения |
| ITRE20090011A1 (it) * | 2009-02-11 | 2010-08-12 | Gianni Magnanini | Composizione terapeutica per il trattamento dell'herpes labialis |
| GB0917086D0 (en) * | 2009-09-29 | 2009-11-11 | Union Of Agricultural Cooperat | Compositon of botanical extracts and their use |
| EP2504408A2 (en) * | 2009-11-25 | 2012-10-03 | DSM IP Assets B.V. | Polyester amide foamers |
| JP2013516499A (ja) * | 2010-01-11 | 2013-05-13 | ヴィトロ‐バイオ・ソシエテ・ア・レスポンサビリテ・リミテ | 局所性ウイルス感染の治療のための新規の相乗的組成物 |
| US20110229537A1 (en) * | 2010-03-17 | 2011-09-22 | Arbonne International Llc | Oral supplement |
| FR2969926B1 (fr) | 2011-01-04 | 2017-03-10 | Elicityl | Arabinogalactanes, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza |
| US8846725B2 (en) | 2011-01-24 | 2014-09-30 | Quadex Pharmaceuticals, Llc | Highly penetrating compositions and methods for treating pathogen-induced disordered tissues |
| EP2573085A1 (en) * | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | N-[5-(aminosulfonyl)-4methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl] acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range |
| CN103070918A (zh) * | 2012-11-14 | 2013-05-01 | 翟立冬 | 一种可以清除hpv病毒的润体油及其制备方法 |
| US9463180B2 (en) | 2013-03-14 | 2016-10-11 | Quadex Pharmaceuticals, Llc | Treatment of molluscum contagiosum |
| US9549930B2 (en) | 2013-03-14 | 2017-01-24 | Quadex Pharmaceuticals, Llc | Combined systemic and topical treatment of disordered and/or prodromal stage tissue |
| US9125911B2 (en) | 2013-03-14 | 2015-09-08 | Quadex Pharmaceuticals, Llc | Combined systemic and topical treatment of disordered tissues |
| CN104138422A (zh) * | 2013-05-09 | 2014-11-12 | 杨东天 | 一种治疗带状疱疹的中药制剂 |
| WO2016014699A1 (en) | 2014-07-22 | 2016-01-28 | Ralco Nutrition, Inc. | Antiviral compositions and methods |
| EP3034129A1 (de) | 2014-12-16 | 2016-06-22 | Agon Pharma GmbH | Verfahren zur Herstellung eines Echinacea purpura Trockenpresssaftes und Verwendung desselben zur Behandlung von Equinem Sarkoid |
| CN105284945B (zh) * | 2015-11-20 | 2018-12-04 | 黄乃宁 | 一种防治甘蔗凤梨病的方法 |
| KR102670487B1 (ko) * | 2016-11-17 | 2024-05-30 | 주식회사 엘지생활건강 | 시나린을 포함하는 구강질환 예방 또는 치료용 조성물 |
| CN107898903A (zh) * | 2017-10-12 | 2018-04-13 | 深圳职业技术学院 | 一种抗疱疹病毒的脂质体乳膏及其制备方法 |
| US11523995B2 (en) * | 2017-11-30 | 2022-12-13 | Duke University | Compositions and methods for ablating niche cells in testis and other epithelial cells and methods relating thereto |
| CN108030796A (zh) * | 2017-12-18 | 2018-05-15 | 王秀兰 | 一种抗流感病毒的蒙药及其制备方法 |
| EP3755368A4 (en) | 2018-02-23 | 2021-12-22 | The Administrators of The Tulane Educational Fund | PHARMACEUTICAL COMPOSITION FOR VIRUS INFECTIONS |
| EA036150B1 (ru) * | 2018-07-17 | 2020-10-05 | Рамида Вагиф Кызы Шадлинская | Средство для лечения и профилактики заболевания пародонта и слизистой ротовой полости |
| CZ307717B6 (cs) * | 2018-08-01 | 2019-03-13 | Fakultní nemocnice Hradec Králové | 1-Alkyl-3-(2-hydroxyethyl)imidazolium-halogenid jako dezinfekční činidlo a dezinfekční kompozice, která jej obsahuje |
| US11931333B1 (en) | 2019-05-28 | 2024-03-19 | Peter Van Horn | Topical treatment of herpes infections |
| CN114821176B (zh) * | 2022-04-28 | 2022-11-01 | 浙江大学 | 一种儿童脑部mr图像病毒性脑炎分类系统 |
| KR20240087518A (ko) | 2022-12-01 | 2024-06-19 | 서울여자대학교 산학협력단 | 카페산을 포함하는 식물바이러스 방제용 조성물 및 이를 이용한 식물바이러스 방제 방법 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4935448A (en) | 1983-01-10 | 1990-06-19 | Baldone Joseph A | Treatment of diseases caused by herpes viruses |
| US4760079A (en) | 1983-01-10 | 1988-07-26 | Baltech, Inc. | Treatment of diseases caused by herpes viruses |
| US4661354A (en) | 1984-06-21 | 1987-04-28 | Finnerty Edmund F | Topical treatment of herpes simplex with a zinc sulfate-camphor water solution |
| US4797420A (en) * | 1984-08-14 | 1989-01-10 | Jabco Manufacturing, Inc. | Disinfectant formulation and method of use |
| US4585656A (en) | 1984-08-20 | 1986-04-29 | Rosenthal Harold R | Treatment of herpes |
| EP0213099A3 (de) | 1985-08-23 | 1989-07-19 | Cederroth Nordic Aktiebolag | Mittel mit antiphlogistischer, immunstimulierender und zytoprotektiver Wirkung, ihre Herstellung und pharmazeutische Verwendungen |
| FR2620698B1 (fr) * | 1987-09-23 | 1990-08-10 | Atlantic Pharma Prod | Fluorure d'ammonium quaternaire et son application dans une substance inhibitrice ou destructrice d'etres vivants unicellulaires |
| US5149529A (en) | 1988-04-08 | 1992-09-22 | Board Of Trustees Of Leland Chiron Corporation | Compositions and treatment for herpes simplex |
| DE4017091A1 (de) | 1990-05-27 | 1991-11-28 | Walter Dr Mach | Molekuelverbundsystem zur kontra-eskalativen therapie viraler infektionskrankheiten |
| US6355684B1 (en) * | 1990-10-11 | 2002-03-12 | Meryl J. Squires | Antimicrobial treatment for herpes simplex virus and other infectious diseases |
| US6348503B1 (en) * | 1996-02-12 | 2002-02-19 | Meryl J. Squires | Method and topical treatment composition for herpesvirus hominis |
| US5461029A (en) | 1992-04-24 | 1995-10-24 | American Cyanamid Company | Method of treating herpes viral infections using HBNF and MK proteins |
| US5455033A (en) * | 1993-05-21 | 1995-10-03 | Degree/Silverman M.D. Inc. | Medicinal composition for treatment of inflammation |
| NL9500216A (nl) | 1995-02-06 | 1996-09-02 | Bio Pharma Sciences Bv | Farmaceutische samenstelling voor de behandeling van herpes. |
-
1996
- 1996-05-08 US US08/646,988 patent/US6355684B1/en not_active Expired - Lifetime
-
1997
- 1997-03-12 RS YUP-505/98A patent/RS49721B/sr unknown
- 1997-03-12 DE DE69737144T patent/DE69737144T2/de not_active Expired - Lifetime
- 1997-03-12 IL IL165980A patent/IL165980A/en not_active IP Right Cessation
- 1997-03-12 JP JP51463098A patent/JP2001505546A/ja active Pending
- 1997-03-12 CN CN97195836A patent/CN1113599C/zh not_active Expired - Lifetime
- 1997-03-12 SK SK1533-98A patent/SK285361B6/sk not_active IP Right Cessation
- 1997-03-12 AU AU37153/97A patent/AU716247B2/en not_active Ceased
- 1997-03-12 EP EP97933985A patent/EP0918458B1/en not_active Expired - Lifetime
- 1997-03-12 CA CA002253736A patent/CA2253736C/en not_active Expired - Lifetime
- 1997-03-12 PL PL97330314A patent/PL188470B1/pl not_active IP Right Cessation
- 1997-03-12 DK DK97933985T patent/DK0918458T3/da active
- 1997-03-12 WO PCT/US1997/002468 patent/WO1998011778A1/en active IP Right Grant
- 1997-03-12 EE EE9800382A patent/EE04605B1/xx not_active IP Right Cessation
- 1997-03-12 TR TR1998/02251T patent/TR199802251T2/xx unknown
- 1997-03-12 ES ES97933985T patent/ES2278393T3/es not_active Expired - Lifetime
- 1997-03-12 NZ NZ332650A patent/NZ332650A/xx unknown
- 1997-03-12 EA EA199800893A patent/EA001339B1/ru active IP Right Revival
- 1997-03-12 AT AT97933985T patent/ATE349159T1/de not_active IP Right Cessation
- 1997-03-12 GE GEAP19974587A patent/GEP20002132B/en unknown
- 1997-03-12 BR BR9711086-8A patent/BR9711086A/pt not_active Application Discontinuation
- 1997-03-12 HU HU9902055A patent/HU229230B1/hu active IP Right Revival
- 1997-03-12 CZ CZ19983594A patent/CZ295869B6/cs not_active IP Right Cessation
- 1997-03-12 KR KR1019980708990A patent/KR100347651B1/ko not_active IP Right Cessation
- 1997-03-12 IL IL12692497A patent/IL126924A/xx not_active IP Right Cessation
- 1997-05-12 AP APAP/P/1998/001386A patent/AP1356A/en active
- 1997-12-03 UA UA98115923A patent/UA65537C2/uk unknown
-
1998
- 1998-11-06 IS IS4888A patent/IS4888A/is unknown
- 1998-11-06 NO NO19985200A patent/NO326139B1/no not_active IP Right Cessation
- 1998-11-06 OA OA9800215A patent/OA10917A/en unknown
- 1998-12-02 BG BG102984A patent/BG64522B1/bg unknown
-
2002
- 2002-03-07 US US10/093,093 patent/US6946490B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO985200D0 (no) | Antimikrobiell behandling for herpes simplex virus, og andre infeksi°se sykdommer | |
| CN112778310A8 (zh) | 核苷类似物或含有核苷类似物的组合制剂在抗病毒中的应用 | |
| HRP20120893T1 (hr) | Formulacija protutijela na histidin-acetatnom puferu | |
| BRPI0210590B8 (pt) | processo de purificação de polissacarídeo capsular bacteriano | |
| WO2001068116A3 (en) | Immunostimulatory polynucleotide sequences for use in preventing and treating respiratory viral infections | |
| BR9915592A (pt) | Processos para conversão das regiões cristalinas meta-estáveis e/ou amorfas de partìculas pré-formadas para um estado essencialmente cristalino para tratamento de uma condição alérgica e/ou inflamatória do nariz ou dos pulmões, para tratamento de doença pulmonar obstrutiva crÈnica (copd), rinite ou asma e para tratamento de doenças de intestino inflamatório (ibd), doença de crohn ou colite ulcerativa, formulação farmacêutica, uso da mesma, partìculas no estado essencialmente cristalino, e, partìculas de lactose mono-hidratada no estado essencialmente cristalino | |
| BRPI9609414B8 (pt) | combinação de vacina e kit para produzir a mesma. | |
| BRPI0410260A (pt) | composição conjugada para medicamento | |
| MA27699A1 (fr) | Vaccin contre vhc | |
| BR0107755A (pt) | Composição parenteral, processo para preparação e utilização dessa composição, processo para o tratamento e prevenção de enfermidades que, envolvem ressorção óssea e dispositivo para liberação local e sistêmica sustentada | |
| RU92016283A (ru) | Производные и аналоги 2-дезокси-2,3-дидегидро-n-ацетилнеураминовой кислоты, способ их получения, их использование в качестве антивирусных агентов, фармацевтическая композиция, способ лечения | |
| NO20051688L (no) | Farmasoytiske blandinger som har en modifisert baerer | |
| BR0316279A (pt) | Compostos orgânicos | |
| PT915707E (pt) | Composicao farmaceutica que compreende um constituinte amiloide p de soro e que se destina ao tratamento profilatico ou terapeutico de infeccoes virais e estojo para a deteccao da fixacao de composicoes aos componentes de virus | |
| RU2009136303A (ru) | Пероральное введение кальцитонина | |
| DE69733089D1 (de) | Behandlung der osteoarthritis durch verabreichung von poly-n-acetyl-d-glucosamin | |
| BR0206995A (pt) | Tratamento do vìrus da hepatite b | |
| HUP0301506A2 (hu) | Gyógyászati készítmények nedves hámfelületek fájdalmas, gyulladásos vagy fekélyes állapotai, így például nyálkahártyagyulladás, szájgyulladás és behcet-tünetcsoport kezelésére | |
| KR960030947A (ko) | src SH2 특이성 화합물의 골흡수 질환 치료 용도 | |
| BRPI0409413A (pt) | composição farmacêutica, uso de um ácido ou sal biliar não conjugado, e, métodos para intensificar a absorção de um princìpio macromolecular ativo em um pacinete e para tratar um paciente que esteja sofrendo de uma condição ou doença tratável | |
| Zahra et al. | Hepatoprotective role of extracts of Momordica charantia L. in acetaminophen-induced toxicity in rabbits. | |
| JP2003504395A5 (no) | ||
| BR112022002612A2 (pt) | Oligonucleotídeo, composição farmacêutica e método para tratar uma doença inflamatória intestinal | |
| WO2020086885A3 (en) | Multivalent glycopeptides that tightly bind to carbohydrate-binding monoclonal antibody family pgt128 | |
| Yadav | Percentage of Swarna Bhasma in medicaments of Ayurveda to treat disorders of different origin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |